Consequently, GPR88 is emerging as a potential drug target for the treatment of various human central nervous system (CNS) related diseases, including schizophrenia, Parkinson’s disease (PD), bipolar disorder, anxiety, depression, and addiction2,3,13. Here, GPR88 is linked to Parkinson disease.